TrialThe Lancet. Respiratory medicine2021

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.

Axel Bauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.